Colin S. Cooper is a leading cancer researcher who is currently Professor of Cancer Genetics at Norwich Medical School at the University of East Anglia.[1][2][3][4]
Colin S. Cooper | |
|---|---|
| Alma mater | University of Warwick University of Birmingham |
| Scientific career | |
| Institutions | University of East Anglia Institute of Cancer Research |
| Thesis | The transcription of DNA by yeast RNA polymerase A (1978) |
Cooper studied science at the University of Warwick and completed his PhD in biochemistry at the University of Birmingham in 1978. He formerly worked at the Institute of Cancer Research, and was Chair of Molecular Biology at the University of London.
He has an h-index of 128 according to Google Scholar.[5]
References
edit- ^ Kovacs, G.; Akhtar, M.; Beckwith, BJ.; Bugert, P.; Cooper, CS.; Delahunt, B.; Eble, JN.; Fleming, S.; et al. (Oct 1997). "The Heidelberg classification of renal cell tumours". J Pathol. 183 (2): 131–3. doi:10.1002/(SICI)1096-9896(199710)183:2<131::AID-PATH931>3.0.CO;2-G. PMID 9390023. S2CID 34796951.
- ^ "Thousands of prostate cancer sufferers could be spared disabling treatment thanks to new test". Daily Mirror. March 2017. Retrieved 2 March 2017.
- ^ "Scientists praised by champion jockey after developing test to stop cancer patients get unnecessary treatment which can cause impotence". Eastern Daily Press. Retrieved 2 March 2017.
- ^ Sample, Ian (19 April 2022). "Discovery of bacteria linked to prostate cancer hailed as potential breakthrough". The Guardian. Retrieved 20 April 2022.
- ^ "Colin Cooper". Google Scholar. Retrieved 13 November 2023.